Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
One Takeda Parkway,
Deerfield, IL 60015
Phone: (224) 554-6500Website: https://www.takeda.us/Careers: www.takeda.com/en-us/careersPatient Assistance Program: www.takeda.com/en-us/corporate-responsib...
Latest news
- Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill
September 30, 2026 - U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations
September 14, 2026 - FDA Approves Orzeyful (oveporexton) to Treat the Underlying Cause of Narcolepsy Type 1
August 5, 2026 - Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
July 16, 2026 - New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
June 15, 2026 - Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
June 11, 2026 - Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
March 28, 2026 - U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
February 10, 2026 - Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
December 18, 2025 - Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
September 8, 2025
Drugs Associated with Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited manufactures, markets and/or distributes more than 57 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
ActoPlus Met
Generic name: metformin/pioglitazone Drug class: antidiabetic combinations |
5 reviews | 6.4 / 10 |
|
Actos
Generic name: pioglitazone Drug class: thiazolidinediones |
40 reviews | 4.8 / 10 |
|
Adderall XR
Generic name: amphetamine/dextroamphetamine Drug class: CNS stimulants |
239 reviews | 8.0 / 10 |
|
Advate
Generic name: antihemophilic factor Drug class: miscellaneous coagulation modifiers |
1 review | 9.0 / 10 |
|
Adynovate
Generic name: antihemophilic factor Drug class: miscellaneous coagulation modifiers |
||
|
Adzynma
Generic name: apadamtase alfa, recombinant Drug class: miscellaneous coagulation modifiers |
1 review | 10 / 10 |
|
Agrylin
Generic name: anagrelide Drug class: miscellaneous coagulation modifiers |
||
|
Amitiza
Generic name: lubiprostone Drug class: chloride channel activators |
270 reviews | 5.6 / 10 |
|
Aralast NP
Generic name: alpha 1-proteinase inhibitor Drug class: miscellaneous respiratory agents |
||
|
Buminate
Generic name: albumin human Drug class: plasma expanders |
||
|
Carbatrol
Generic name: carbamazepine Drug class: dibenzazepine anticonvulsants |
14 reviews | 7.6 / 10 |
|
Ceprotin
Generic name: protein c Drug class: miscellaneous coagulation modifiers |
||
|
Cinryze
Generic name: C1 esterase inhibitor (human) Drug class: hereditary angioedema agents |
3 reviews | 7.7 / 10 |
|
Colcrys
Generic name: colchicine Drug class: antigout agents |
24 reviews | 7.8 / 10 |
|
Cuvitru
Generic name: immune globulin subcutaneous Drug class: immune globulins |
13 reviews | 8.8 / 10 |
|
Dexilant
Generic name: dexlansoprazole Drug class: proton pump inhibitors |
206 reviews | 6.7 / 10 |
|
Duetact
Generic name: glimepiride/pioglitazone Drug class: antidiabetic combinations |
||
|
Elaprase
Generic name: idursulfase Drug class: lysosomal enzymes |
||
|
Entyvio
Generic name: vedolizumab Drug class: selective immunosuppressants |
162 reviews | 6.4 / 10 |
|
Eohilia
Generic name: budesonide Drug class: glucocorticoids |
8.3 / 10 | |
|
Feiba
Generic name: anti-inhibitor coagulant complex |
||
|
Firazyr
Generic name: icatibant Drug class: hereditary angioedema agents |
7 reviews | 7.9 / 10 |
|
Flexbumin
Generic name: albumin human Drug class: plasma expanders |
||
|
Fosrenol
Generic name: lanthanum carbonate Drug class: phosphate binders |
6 reviews | 7.7 / 10 |
|
Fruzaqla
Generic name: fruquintinib Drug class: multikinase inhibitors, VEGF/VEGFR inhibitors |
||
|
Gammagard Liquid
Generic name: immune globulin intravenous and subcutaneous Drug class: immune globulins |
7 reviews | 8.2 / 10 |
|
Gammagard S/D
Generic name: immune globulin intravenous Drug class: immune globulins |
2 reviews | 7.0 / 10 |
|
Gattex
Generic name: teduglutide Drug class: miscellaneous GI agents |
5 reviews | 8.3 / 10 |
|
Glassia
Generic name: alpha 1-proteinase inhibitor Drug class: miscellaneous respiratory agents |
1 review | 7.0 / 10 |
|
Hemofil-M
Generic name: antihemophilic factor Drug class: miscellaneous coagulation modifiers |
||
|
Hyqvia
Generic name: hyaluronidase/immune globulin Drug class: immune globulins |
6.5 / 10 | |
|
Intuniv
Generic name: guanfacine Drug class: antiadrenergic agents, centrally acting |
166 reviews | 6.5 / 10 |
|
Kalbitor
Generic name: ecallantide Drug class: hereditary angioedema agents |
2 reviews | 10 / 10 |
|
Kazano
Generic name: alogliptin/metformin Drug class: antidiabetic combinations |
2 reviews | 5.0 / 10 |
|
Lialda
Generic name: mesalamine Drug class: 5-aminosalicylates |
105 reviews | 6.8 / 10 |
|
Livtencity
Generic name: maribavir Drug class: miscellaneous antivirals |
||
|
Mimrylo
Generic name: rusfertide |
||
|
Motegrity
Generic name: prucalopride Drug class: serotoninergic neuroenteric modulators |
69 reviews | 6.0 / 10 |
|
Mydayis
Generic name: amphetamine/dextroamphetamine Drug class: CNS stimulants |
144 reviews | 5.8 / 10 |
|
Natpara
Generic name: parathyroid hormone Drug class: parathyroid hormone and analogs |
6 reviews | 7.7 / 10 |
|
Nesina
Generic name: alogliptin Drug class: dipeptidyl peptidase 4 inhibitors |
4 reviews | 2.5 / 10 |
|
Obizur
Generic name: antihemophilic factor Drug class: miscellaneous coagulation modifiers |
||
|
Orzeyful
Generic name: oveporexton |
||
|
Oseni
Generic name: alogliptin/pioglitazone Drug class: antidiabetic combinations |
2 reviews | 3.5 / 10 |
|
Pentasa
Generic name: mesalamine Drug class: 5-aminosalicylates |
89 reviews | 7.7 / 10 |
|
Prevacid
Generic name: lansoprazole Drug class: proton pump inhibitors |
59 reviews | 7.9 / 10 |
|
Prevacid SoluTab
Generic name: lansoprazole Drug class: proton pump inhibitors |
3 reviews | 6.7 / 10 |
|
Prevpac
Generic name: amoxicillin/clarithromycin/lansoprazole Drug class: H. pylori eradication agents |
81 reviews | 7.3 / 10 |
|
Recombinate
Generic name: antihemophilic factor Drug class: miscellaneous coagulation modifiers |
1 review | 10 / 10 |
|
Rixubis
Generic name: coagulation factor ix Drug class: miscellaneous coagulation modifiers |
||
|
Rozerem
Generic name: ramelteon Drug class: miscellaneous anxiolytics, sedatives and hypnotics |
104 reviews | 4.3 / 10 |
|
Takhzyro
Generic name: lanadelumab Drug class: hereditary angioedema agents |
3 reviews | 9.8 / 10 |
|
Trintellix
Generic name: vortioxetine Drug class: miscellaneous antidepressants |
1129 reviews | 6.0 / 10 |
|
Uloric
Generic name: febuxostat Drug class: antihyperuricemic agents |
46 reviews | 7.7 / 10 |
|
Vonvendi
Generic name: von willebrand factor Drug class: miscellaneous coagulation modifiers |
||
|
VPRIV
Generic name: velaglucerase alfa Drug class: lysosomal enzymes |
||
|
Vyvanse
Generic name: lisdexamfetamine Drug class: CNS stimulants |
973 reviews | 7.4 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
ActoPlus Met XR
Generic name: metformin/pioglitazone Drug class: antidiabetic combinations |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||